Found 13 articles for: "Vitiligo"

A Review of the Vitiligo Literature to Standardize Expression of Disease Severity

October 2024 | Volume 23 | Issue 10 | Original Article | 842 | Copyright © October 2024

Representation of Skin of Color in Social Media Discussions on Melasma, Keloids, and Vitiligo

July 2024 | Volume 23 | Issue 7 | Original Article | 510 | Copyright © July 2024

Racial and Ethnic Diversity in Vitiligo Clinical Trials: A Retrospective Cross-Sectional Study Assessing Demographic Reporting of Participants

July 2024 | Volume 23 | Issue 7 | Editorials | e164 | Copyright © July 2024

The Pediatric Dermatologist's View of Pediatric Vitiligo

February 2024 | Volume 23 | Issue 2 | Editorials | e77 | Copyright © February 2024

A Review on the Use of Topical Ruxolitinib for the Treatment of Vitiligo

July 2023 | Volume 22 | Issue 7 | Original Article | 664 | Copyright © July 2023

Shining a Light on Vitiligo and Associated Comorbidities: What Is the Evidence?

April 2023 | Volume 22 | Issue 4 | Features | 428 | Copyright © April 2023

Citation: Desai S, McCormick E, Sodha P, et al. Shining a light on the vitiligo and associated comorbidities: What is the evidence? J Drugs Dermatol. 2023;22(4):428-430. doi:10.36849...
Read More

Refractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy

December 2022 | Volume 21 | Issue 12 | Case Reports | 1366 | Copyright © December 2022

Background: In the last several years, oral tofacitinib has become an increasingly utilized off-label treatment option for immune-mediated skin conditions such as alopecia areata (AA)...
Read More

A Potential Alternative Treatment for Vitiligo: An Observational Study on Tacrolimus 0.3% Lotion

December 2022 | Volume 21 | Issue 12 | Features | 1370 | Copyright © December 2022

Vitiligo is a complex multifactorial disorder of depigmentation affecting 0.5 to 2% of the world's population without specific gender or racial prevalence.¹ Though no treatments are FDA app...
Read More

Social Media Platforms as a Resource for Vitiligo Support

October 2022 | Volume 21 | Issue 10 | Editorials | 1135 | Copyright © October 2022

Social media use among dermatology patients is ubiquitous, with estimates of over 80% of patients using social media to learn about their dermatologic conditions. Vitiligo is an autoimmune disease lea...
Read More

Short and Long-Term Outcomes of 308-nm Laser for Pediatric Vitiligo

July 2022 | Volume 21 | Issue 7 | Original Article | 773 | Copyright © July 2022

Pediatric vitiligo is often challenging to treat. Children with vitiligo experience stigma, bullying, and emotional distress. The long-term outcome of therapeutics used to treat pediatric vitiligo has...
Read More

Vitiligo Health Education: A Study of Accuracy and Engagement of Online Educational Materials

June 2021 | Volume 20 | Issue 6 | Original Article | 623 | Copyright © June 2021

Introduction: Many vitiligo patients seek healthcare information online. However, the accuracy and quality of this information is unknown.
Objective: To determi...
Read More

A Multi-Centered Case-Control Study of Vitiligo Support Groups and Quality of Life

June 2021 | Volume 20 | Issue 6 | Original Article | 672 | Copyright © June 2021

Background: There is limited research on the association between vitiligo support group membership and patient quality of life (QoL).
Objectives: To explore the...
Read More

Comparative Evaluation of Efficacy and Safety of Tacrolimus and Dinoprostone Following Dermabrasion in Stable Vitiligo

May 2021 | Volume 20 | Issue 5 | Original Article | 519 | Copyright © May 2021

Background: Dinoprostone (DNP), a prostaglandin E2 (PGE2) analogue, has been found to cause repigmenation in vitiliginous lesions. Combined medical and surgical therapy might be more ...
Read More